We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
From March 23, 2020, to June 23, 2020, 1136 skin cancer diagnoses were reported to the Northern Cancer Network in the UK, which was a 68.61% decrease from the same time period last year (n=3619).
Wait time to treatment of skin cancer also decreased during this time period (median, 8 days during Covid-19 vs 12 days before Covid-19), likely due to a decrease in overall dermatology referrals and prioritization of skin cancer referrals during the pandemic.
– Caitlyn T. Reed, MD
This abstract is available on the publisher's site.
The UK healthcare system has been profoundly affected by the COVID-19 Pandemic, including skin cancer departments. Despite service capacity and a worldwide increase in incidence, anecdotal reports suggest a decline in skin cancer diagnoses following COVID-19. To determine if there is a decrease in skin cancer diagnosis in the UK in the COVID-19 era, we analysed data from the Northern Cancer Network from March 23rd 2020 to June 23rd 2020 and compared it to the same period last year. In the COVID Period there was a decrease in skin cancer diagnoses of 68.61% from 3619 to 1136 (p<0.0028). Surprisingly, skin cancer waiting times were also reduced in the COVID Period compared to Before COVID Period (median 8 days and 12 days respectively; p<0.0001). Collectively these data highlight a statistically significant reduction in both skin cancer diagnoses and waiting times during the COVID Period.